BioCentury | Feb 4, 2008
Company News

Cryo-Cell, Saneron deal

...Cryo-Cell and Saneron will study Cryo-Cell’s C’elle menstrual stem cells in preclinical models of undisclosed neurological...
...were not disclosed. Cryo-Cell owns about 38% of Saneron. Cryo-Cell International Inc. (OTCBB:CCEL), Oldsmar, Fla. Saneron CCEL Therapeutics Inc....
BioCentury | Dec 5, 2005
Company News

Saneron CCEL Therapeutics Inc., General Electric deal

...is used to isolate stem cells from umbilical cord blood. Further terms were not disclosed. Saneron CCEL Therapeutics Inc....
BioCentury | Sep 12, 2005
Company News

Saneron CCEL Therapeutics Inc., University of Minnesota deal

...Saneron acquired exclusive, worldwide patent rights to the university's cord blood cell line. Saneron will use...
...neurological and cardiovascular disorders. The university will receive research funding and is eligible for milestones. Saneron CCEL Therapeutics Inc....
BioCentury | Aug 15, 2001
Company News

Saneron, Ccel Bio-therapies to merge

...of cord blood stem cell storage play Cryo-Cell (CCEL), will merge with Saneron to form Saneron...
...Ccel Therapeutics. The merged company will combine Ccel Bio-Therapies' U-Cord blood stem cell technology with Saneron's...
...therapies for stroke, brain injuries, Alzheimer's disease and Parkinson's disease. CCEL will own 40% of Saneron...
Items per page:
1 - 4 of 4
BioCentury | Feb 4, 2008
Company News

Cryo-Cell, Saneron deal

...Cryo-Cell and Saneron will study Cryo-Cell’s C’elle menstrual stem cells in preclinical models of undisclosed neurological...
...were not disclosed. Cryo-Cell owns about 38% of Saneron. Cryo-Cell International Inc. (OTCBB:CCEL), Oldsmar, Fla. Saneron CCEL Therapeutics Inc....
BioCentury | Dec 5, 2005
Company News

Saneron CCEL Therapeutics Inc., General Electric deal

...is used to isolate stem cells from umbilical cord blood. Further terms were not disclosed. Saneron CCEL Therapeutics Inc....
BioCentury | Sep 12, 2005
Company News

Saneron CCEL Therapeutics Inc., University of Minnesota deal

...Saneron acquired exclusive, worldwide patent rights to the university's cord blood cell line. Saneron will use...
...neurological and cardiovascular disorders. The university will receive research funding and is eligible for milestones. Saneron CCEL Therapeutics Inc....
BioCentury | Aug 15, 2001
Company News

Saneron, Ccel Bio-therapies to merge

...of cord blood stem cell storage play Cryo-Cell (CCEL), will merge with Saneron to form Saneron...
...Ccel Therapeutics. The merged company will combine Ccel Bio-Therapies' U-Cord blood stem cell technology with Saneron's...
...therapies for stroke, brain injuries, Alzheimer's disease and Parkinson's disease. CCEL will own 40% of Saneron...
Items per page:
1 - 4 of 4